![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 32, 22143-22146, August 6, 1999
From the Formylation of the initiator methionyl-tRNA,
catalyzed by methionyl-tRNA formyltransferase, has long been regarded
as essential for initiation of protein synthesis in eubacteria. Here,
we show that this process is, in fact, dispensable in Pseudomonas
aeruginosa. Disruption of the chromosomal methionyl-tRNA
formyltransferase gene in P. aeruginosa resulted only in a
moderate decrease in the rate of cell growth, whereas in
Escherichia coli cell growth was severely impaired. The
ability of the P. aeruginosa mutant strain to grow was not
due to an additional copy of the methionyl-tRNA formyltransferase gene
or to N-acylation of the methionyl moiety by a group other
than formyl. These results indicate that P. aeruginosa can
carry out formylation-independent initiation of protein synthesis, using the nonformylated methionyl-tRNA. Therefore, the dogma that eubacteria require formylation of the initiator methionyl-tRNA for
initiation of protein synthesis may have been an invalid generalization of results obtained with E. coli.
Protein synthesis in eubacteria, and in the chloroplasts and
mitochondria of eukaryotes, can be initiated using the initiator formyl-methionyl-tRNA
(fMet-tRNAfMet)1
(1). Formylation is specific for the initiator methionyl-tRNA (Met-tRNAfMet) and is catalyzed by methionyl-tRNA
formyltransferase (MTF), which is encoded by the fmt gene
(2-5). The features in the Escherichia coli
tRNAfMet required for formylation are the base-base
mismatch between nucleotides 1 and 72 and the second and third base
pairs of the acceptor stem (4-6). The fMet moiety allows initiation
factor IF-2 to recognize the initiator tRNA and reject other tRNAs.
This conclusion is based on in vivo analysis of the effect
of overproduction of IF-2 on the activity of E. coli
tRNAfMet mutants defective in formylation (7, 8) and on
in vitro studies of IF-2 interaction with
N-blocked aminoacyl-tRNA (9, 10). The formyl group also
prevents the tRNAfMet from participating in elongation by
blocking binding of elongation factor EF-Tu (5, 7).
Formylation of the Met-tRNAfMet is generally accepted as a
key checkpoint required for initiation of protein synthesis in
eubacteria. This dogma, based primarily on studies conducted in
E. coli, was further substantiated by the finding that
disruption of the E. coli chromosomal fmt gene
severely curtailed cell growth (3). However, some earlier studies have
obtained circumstantial evidence that questioned this generalization. A
Streptococcus faecalis folate-deficient strain, which is
unable to synthesize the formyl donor
N10-formyltetrahydrofolate (fTHF), was shown to
be unaffected in growth or viability (11). However, it was not clear
that S. faecalis can initiate protein synthesis in the
absence of formylation, since the strain also incurred additional
chromosomal mutations that affect proper tRNA modification (11).
While the studies in S. faecalis were inconclusive, they
hinted that formylation may not be a prerequisite for initiation of
protein synthesis in all eubacteria. Therefore, we investigated the
significance of the formylation step in Pseudomonas
aeruginosa, a Gram-negative, opportunistic pathogen that is
distantly related to E. coli. The results show that the
process of initiation of protein synthesis in P. aeruginosa
is not strictly dependent on formylation and can accommodate the use of
non-N-blocked Met-tRNAfMet. The extent to which
other eubacteria have this capacity to initiate translation thus
becomes an open question.
Materials--
The plasmids pEX100T (12), pUCGM (13), and pUCP26
(14) and the P. aeruginosa PAO1 strain were provided by Dr.
J. S. Lam, Department of Microbiology, University of Guelph. The
pACTN vector was described previously (15). The E. coli
methionyl-tRNA synthetase (MetRS) and initiator tRNA (15) and P. aeruginosa MTF (15, 16) were overproduced and purified as
described. The fmt-deficient strain of E. coli
was constructed previously (16).
Construct for Expression of the P. aeruginosa and E. coli MTFs in
the E. coli fmt Mutant Strain--
The open reading frame (ORF) of the
fmt genes was cloned into the NcoI and
BamHI sites in pACTN (15). In this construct, the
fmt genes are under the control of the Lac
promoter and the Shine-Dalgarno and transcription termination sequences
of gene 10 of bacteriophage T7.
Construct for Expression of the P. aeruginosa MTF in the P. aeruginosa fmt Mutant Strain--
A 1.4-kilobase pair KpnI
fragment containing the wild type P. aeruginosa fmt gene was
inserted into the same site in the P. aeruginosa shuttle
vector pUCP26. The cloned fragment is under the control of the
Lac promoter.
Disruption of the Chromosomal P. aeruginosa fmt Gene--
The
P. aeruginosa fmt gene on a 6-kilobase pair fragment was
isolated previously from a genomic library (GenBankTM
accession number AF073952) (16). A 4.5-kilobase pair SmaI segment containing the fmt gene and flanking sequences was
obtained from the 6-kilobase pair fragment and inserted into the same
site of pEX100T. An 840-base pair fragment containing the gentamycin resistance gene (GmR) was obtained by PCR amplification
using pUCGM as the template. The fragment was digested with
MfeI and inserted into the same site in the fmt
gene on pEX100T. The pEX100Tfmt::GmR
construct was used to replace the chromosomal MTF gene of the P. aeruginosa PAO1 strain (12). Gene replacement was verified by PCR
analysis using primers complementary to the 5' and 3' ends of
the fmt ORF. The sequence of the primers are
5'-TTTTCCATGGCGATGAGCCAAGCATTGCGC-3' and
5'-TTTGGATCCTCATTGGCCGAGCACCTG-3'.
Preparation of Cell Extracts--
The wild type and mutant
fmt P. aeruginosa strains harboring the pUCP26 vector
without the fmt gene were grown overnight at 37 °C in
Luria-Bertani medium supplemented with 60 µg/ml tetracycline. An
aliquot of the cultures were diluted 50-fold into 3 ml of medium containing tetracycline and grown for 3 h at 37 °C. Cells from 1.2 ml of culture was pelleted by centrifugation and lysed (8). The
cell lysate was centrifuged and an aliquot of the supernatant was mixed
with 3 volumes of 25.6 mM Tris-HCl, pH 8.0, 13.3 mM Measurement of MTF Activity--
The initiator tRNA substrate
was acylated with methionine at 37 °C for 30 min. The incubation
mixture (20 µl) consisted of 20 mM imidazole HCl, pH 7.5, 150 mM NH4Cl, 10 mM
MgCl2, 0.1 mM EDTA, 10 µg/ml bovine serum
albumin, 100 µM methionine (specific activity:
13,000-15,000 cpm/pmol), 2 mM ATP, 5 µM
tRNAfMet, and an excess of MetRS (1 µg). To measure the
formylation activity in cell extracts, 5 µl of 1.8 mM of
fTHF in 20 mM imidazole HCl, pH 7.5, and 5 µl of
appropriately diluted MTF were added, and the incubation mixture was
incubated for 10 min at 37 °C. The reaction was terminated by the
addition of 30 µl of 360 mM copper sulfate in 1.1 M Tris, pH 7.3. After 5 min an aliquot was spotted on
Whatman No. 3MM filter paper and washed sequentially with 10% trichloroacetic acid containing 0.2% casamino acids, 5%
trichloroacetic acid containing 0.2% casamino acids, and cold 95%
ethanol. The retained radioactivity was determined by liquid
scintillation counting.
Determination of the Amount of N-Blocked Met-tRNAfMet
in the Wild Type and Mutant fmt P. aeruginosa Strains--
The wild
type and mutant strains carrying the pUCP26 vector were grown at
37 °C in 100 ml of Luria-Bertani medium containing 60 µg/ml
tetracycline to an A600 of 1. The cells were
pelleted and resuspended in 1 ml of 300 mM sodium acetate,
pH 4.8, buffer containing 10 mM NaEDTA (3). Total tRNA was
extracted from the cells with phenol and purified under acidic
conditions at 4 °C (3). A portion of the tRNA samples was completely
deacylated by a 90-min incubation at 37 °C in 0.5 ml of 2 M Tris-HCl, pH 8.0. Cleavage of the ester linkage of
aminoacyl-tRNAs in another portion of the samples was carried out for
30 min at 37 °C in 0.5 ml of 200 mM sodium acetate, pH
5.0, buffer containing 10 mM CuSO4. 0.5 A260 units of tRNA from the fully deacylated and CuSO4-treated samples were acylated with methionine for 5 min using a large excess of MetRS. Formylation was carried out for 5 min using a large excess of affinity purified P. aeruginosa MTF. The amount of N-blocked Met-tRNAfMet in
each strain was determined by the difference between formyl acceptance
of the two tRNA samples and expressed as a percent of the total
tRNAfMet in the completely deacylated sample.
In vitro studies of protein synthesis using extracts
from E. coli showed that translation was stimulated by
fMet-tRNAfMet (17). Furthermore, inhibition of formylation
in E. coli by using trimethoprim to impair folate metabolism
caused the cells to grow very slowly (18-20). These early studies led
to the belief that formylation is an important prerequisite for
initiation of protein synthesis in eubacteria. Recently, this view was
supported by the finding that inactivation of the E. coli
chromosomal fmt gene, which codes for the formylating
enzyme, severely curtailed cell growth (3). Both in vitro
and in vivo studies showed that the formyl group is
important for selection of the initiator tRNA by IF-2 at the initiation
site of the ribosome and for preventing misappropriation of the tRNA in
elongation (5, 7-10).
Some circumstantial evidence obtained from studies conducted in
S. faecalis and Bacillus subtilis questioned the
importance of formylation in initiation of protein synthesis in
eubacteria. In contrast to E. coli, B. subtilis
was capable of growth when formylation was blocked by trimethoprim
inhibition of folate metabolism (21). Similarly, a S. faecalis mutant deficient in folate synthesis was not affected in
growth (11). In the case of S. faecalis, the selection
conditions used to isolate the mutant strain resulted in additional
chromosomal mutations, which affected proper tRNA modification. This
observation suggests that growth of B. subtilis could be due
to compensatory chromosomal mutations. Therefore, it is not clear
whether formylation is required for initiation of protein synthesis in
these organisms.
Disruption of the P. aeruginosa Chromosomal MTF Gene--
To
investigate the importance of Met-tRNAfMet formylation in
P. aeruginosa, the chromosomal fmt gene was
replaced with a mutant copy by homologous recombination (12). The
fmt gene used in this study was isolated previously from a
genomic library by functional complementation of a MTF-deficient
E. coli strain (16). A 4.5-kilobase pair SmaI
segment containing the fmt gene as well as flanking sequences was obtained from the genomic clone and inserted into the
same site in the suicide vector pEX100T. The fmt gene was inactivated by insertion of the GmR cassette into a
MfeI site. P. aeruginosa transformants containing the pEX100Tfmt::GmR vector in the
chromosome were identified by selecting for carbenicillin and
gentamycin resistance. Resolution of the plasmid was achieved by
subjecting the merodiploid strain to sucrose counter-selection in the
presence of gentamycin.
Several sucrose- and gentamycin-resistant colonies were observed within
24 h of incubation at 37 °C. Replacement of the wild type
fmt gene with the mutant copy was verified by PCR analysis using primers complementary to the 5' and 3' ends of the fmt
ORF (Fig. 1). Two products of about 1.7- and 1-kilobase pair, corresponding to the
fmt::GmR fragment (compare lanes
1 and 4) and the wild type fmt ORF (compare lanes 1 and 3), respectively, were obtained when
the chromosomal DNA from the merodiploid strain was used (lane
1). The presence of the fmt::GmR
fragment and absence of the wild type fmt gene confirmed
replacement of the chromosomal copy in one of the isolates (lane
2).
Formylation Is Less Important in P. aeruginosa than in E. coli--
The P. aeruginosa MTF mutant strain grew with a
doubling time of 152 min (Fig.
2A). Complementation with the
wild type fmt gene, provided in trans on the plasmid pUCP26,
decreased the doubling time of the mutant strain to 56 min. This is
comparable with that of the wild type strain harboring the pUCP26
vector with or without the fmt gene (Fig. 2A).
This finding established that the reduced growth rate of P. aeruginosa was due specifically to inactivation of the chromosomal
fmt gene. The E. coli MTF mutant, constructed as
described previously (3, 16, 22), doubled every 474 min, whereas the
mutant strain expressing the wild type E. coli or P. aeruginosa fmt ORFs grew with a doubling time of 42-46 min (Fig.
2B). The residual growth of the E. coli mutant
strain is probably due to some low level utilization of the
unformylated Met-tRNAfMet in initiation. The growth rate of
the MTF-deficient E. coli strain was reduced by 12-fold and
that of the P. aeruginosa mutant strain was reduced by
3-fold. The distinct growth phenotype of the two mutant strains
suggests that formylation is less important in P. aeruginosa
than in E. coli.
Growth of the P. aeruginosa fmt mutant strain was not due to
the presence of a homologue of MTF or to the mutant MTF enzyme being
active. This conclusion is based on measurement of formylation activity
in cell extracts prepared from the wild type and mutant strains (Fig.
3). The total activity in cell extracts
prepared from the wild type parental strain increased with the amount
of protein assayed. In contrast, no formylation activity was detected in cell extracts prepared from the mutant strain even at high protein
levels. These results show that the P. aeruginosa fmt mutant
strain was devoid of formylating activity.
P. aeruginosa Has the Capacity to Initiate Protein Synthesis with
Non-N-blocked Met-tRNAfMet--
We investigated whether
N-acylation of the Met-tRNAfMet by a functional
group other than the formyl group could account for the growth of the
P. aeruginosa fmt mutant strain. Total tRNAs were isolated
from the wild type and mutant strains, under conditions that stabilize
the aminoacyl ester linkage (3). One portion of the sample was
completely deacylated, by incubating the tRNA under alkaline
conditions. A second portion was treated with CuSO4, which
cleaves the ester bond of aminoacyl-tRNA but not that of N-acyl-Met-tRNAfMet. Both tRNA samples were
re-acylated with methionine, and formyl acceptance was measured using
P. aeruginosa MTF overproduced in E. coli and
purified by affinity chromatography (15). The amount of
N-blocked Met-tRNAfMet in the wild type and
mutant MTF strains was determined by the difference between formyl
acceptance of the completely deacylated and CuS04-treated
tRNA samples. Based on this analysis, 80% of the
Met-tRNAfMet in the wild type strain was
N-blocked (Fig. 4). However,
only the unblocked Met-tRNAfMet species was found in the
mutant strain. This result showed that the Met-tRNAfMet in
the MTF-deficient strain was not N-acylated by another
group. Taken altogether, the results indicate that protein synthesis in
the MTF-deficient P. aeruginosa strain is initiated with the initiator methionyl-tRNA and not with N-blocked
Met-tRNAfMet.
In archaebacteria and the cytoplasm of eukaryotes, protein synthesis is
initiated with the initiator Met-tRNA (23). These initiator tRNAs
contain an A:U base pair which is, in part, required for initiation
factor (eIF) recognition of the tRNA (24). In contrast, eubacterial
initiator tRNAs contain a C × A mismatch between nucleotides 1 and 72. The mismatch in the E. coli initiator tRNA is a key
formylation determinant (4-6). Therefore, for initiation in the
absence of formylation, it is possible that P. aeruginosa is
using an initiator tRNA with functional properties comparable with
those of eukaryotes. A search of the P. aeruginosa genome sequence data base identified two initiator tRNA genes encoding tRNAs
that are almost identical. The sequences of the initiator tRNAs are
homologous to the E. coli tRNAfMet (Fig.
5). Moreover, the P. aeruginosa tRNAs contain a C × A mismatch between
nucleotides 1 and 72. This feature was used by the P. aeruginosa MTF to recognize the initiator tRNA, since
overproduction of the enzyme increased the initiator activity of a
formylation-defective tRNAfMet mutant with a base pair
between nucleotides 1 and 72 (data not shown). These results suggest
that P. aeruginosa is using the tRNAfMet and not
a unique initiator tRNA to initiate protein synthesis in the absence of
formylation.
IF-2 is essential for initiation of protein synthesis in E. coli (25). The protein has a higher affinity for the
fMet-tRNAfMet than for the Met-tRNAfMet,
indicating that the formyl group is an IF-2 recognition element (9,
10). In vitro studies showed that IF-2 selects the
fMet-tRNAfMet at the initiation site of the preinitiation
complex (9). Therefore, in E. coli, IF-2 is partly
responsible for excluding the participation of the nonformylated
Met-tRNAfMet in initiation. This is consistent with the
observation that in the MTF-deficient E. coli strain,
initiation of protein synthesis is severely impaired. The eIF-2s of
archaebacteria and eukaryotic cytoplasm are involved in selecting the
initiator Met-tRNA for utilization in initiation of translation. A
BLAST search of the P. aeruginosa genome data base
identified sequences that were homologous to the E. coli
IF-2 gene but none that were homologous for the eIF-2 gene. Therefore,
it is conceivable that the P. aeruginosa IF-2 has dual
substrate specificity and facilitates utilization of both
Met-tRNAfMet and fMet-tRNAfMet in initiation or
that an unidentified initiation factor, which only recognizes the
Met-tRNAfMet species, is involved.
We have shown that P. aeruginosa can carry out
formylation-independent initiation of protein synthesis, using the
Met-tRNAfMet. This finding represents the first direct
evidence that eubacteria have the ability to initiate translation with
fMet-tRNAfMet and Met-tRNAfMet. While it is not
known whether this phenomenon is unique to P. aeruginosa, it
opens the possibility that other eubacteria may have the capacity to
use both forms of the tRNAfMet for initiation. The
availability of various fmt sequences will facilitate
investigation of this question in both Gram-positive and Gram-negative bacteria.
We thank Dr. J. S. Lam for the P. aeruginosa PAO1 strain and vectors. We also thank our colleagues,
Drs. P. D. Josephy, F. J. Sharom, R. A. B. Keates,
and A. R. Merrill, for their helpful suggestions during the
preparation of this manuscript.
*
This work was supported by a research grant from the Natural
Sciences and Engineering Research Council of Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.: 519-824-4120 (Ext. 3432); Fax: 519-766-1499; E-mail: mangroo@chembio.uoguelph. ca.
The abbreviations used are:
fMet-tRNAfMet, formyl-methionyl-tRNA, Met-tRNAfMet, methionyl-tRNA;
tRNAfMet, initiator tRNA, MTF, methionyl-tRNA
formyltransferase;
ORF, open reading frame;
fTHF, N10-formyltetrahydrofolate;
IF-2, initiation
factor IF-2.
COMMUNICATION
Formylation Is Not Essential for Initiation of Protein Synthesis
in All Eubacteria*
,
¶
Guelph-Waterloo Center for Graduate Work
in Chemistry and Biochemistry,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-mercaptoethanol, 200 mM KCl, and 66%
glycerol (w/v) and stored at
20 °C (8).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (67K):
[in a new window]
Fig. 1.
Verification that the P. aeruginosa chromosomal fmt gene was
disrupted. Replacement of the chromosomal fmt gene with
the mutant copy was verified by PCR analysis using primers
complementary to the 5' and 3' ends of the fmt ORF and
chromosomal DNA from the merodiploid (lane 1), MTF mutant
(lane 2), and wild type (lane 3) strains. The
pEX100fmt::GmR DNA was used as a
control (lane 4).

View larger version (21K):
[in a new window]
Fig. 2.
Growth phenotype of the P. aeruginosa and E. coli MTF mutant
strains. A, the P. aeruginosa PAO1 strains
harboring the pUCP26 vector without (
,
) and with the P. aeruginosa fmt gene (
,
) were grown at 37 °C in
Luria-Bertani medium containing 60 µg/ml tetracycline. B,
the E. coli MTF-deficient strain harboring the pACTN vector
without (
) and with the E. coli (
) or P. aeruginosa (
) fmt gene was grown at 37 °C in 100 ml of Luria-Bertani medium supplemented with 100 µg/ml ampicillin, 10 µg/ml tetracycline, 25 µg/ml kanamycin, and 1 mM
isopropyl-
-D-thiogalactopyranoside. At the times
indicated the optical density of the cultures was measured at 600 nm.
The doubling time for each strain is shown in the
inset.

View larger version (16K):
[in a new window]
Fig. 3.
Formylating activity in cell extract prepared
from the wild type and mutant fmt P. aeruginosa
strains. Cell extracts were prepared from the wild type
(
) and mutant (
) strains carrying the pUCP26 vector alone. The
formylation activity in each extract was measured as described under
"Experimental Procedures."

View larger version (28K):
[in a new window]
Fig. 4.
Determination of the amount of
N-blocked Met-tRNAfMet in the P. aeruginosa MTF-deficient strain. The amount of
N-blocked Met-tRNAfMet in the wild type and
mutant MTF strains was determined by the difference between formyl
acceptance of the completely deacylated and CuSO4-treated
tRNA samples and expressed as a percent of the total
tRNAfMet in the completely deacylated sample (see
"Experimental Procedures"). The data reported are averages of
assays on three independent preparations.

View larger version (18K):
[in a new window]
Fig. 5.
Nucleotide sequences of the P. aeruginosa and E. coli initiator
tRNAs. The P. aeruginosa initiator tRNA sequence was
obtained by a BLAST search of the National Center for Biotechnology
Information P. aeruginosa data base for sequences homologous
to that of the E. coli initiator tRNA. The boxes
indicate the determinants that are important for MTF recognition of the
initiator tRNA. The arrows denote the most crucial of the
three formylation determinants. The asterisks signify the
nucleotides that are different between the P. aeruginosa and
E. coli tRNAs.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Marcker, K.,
and Sanger, F.
(1963)
J. Mol. Biol.
8,
835-840
2.
Dickerman, H. W.,
Steers, E., Jr.,
Redfield, B. G.,
and Weissbach, H.
(1967)
J. Biol. Chem.
242,
1522-1525 3.
Guillon, J.-M.,
Mechulam, Y.,
Schmitter, J.-M.,
Blanquet, S.,
and Fayat, G.
(1992)
J. Bacteriol.
174,
4294-4301 4.
Lee, C.-P.,
Seong, B. L.,
and RajBhandary, U. L.
(1991)
J. Biol. Chem.
266,
18012-18017 5.
Varshney, U.,
Lee, C.-L.,
Seong, B. L.,
and RajBhandary, U. L.
(1991)
J. Biol. Chem.
266,
18018-18024 6.
Guillon, J.-M.,
Meinnel, T.,
Mechulan, Y.,
Laxennec, C.,
Blanquet, S.,
and Fayat, G.
(1992)
J. Mol. Biol
224,
359-367[CrossRef][Medline]
[Order article via Infotrieve]
7.
Guillon, J.-M.,
Heiss, S.,
Soutourina, J.,
Mechulam, Y.,
Laalami, S.,
and Grunberg-Manago, M.
(1996)
J. Biol. Chem.
271,
22321-22325 8.
Mangroo, D.,
and RajBhandary, U. L.
(1995)
J. Biol. Chem.
270,
12203-12209 9.
Hartz, D.,
McPheeters, D. S.,
and Gold, L.
(1989)
Genes Dev.
3,
1899-1912 10.
Sundari, R.,
Stringer, E. A.,
Schulman, L. H.,
and Maitra, U.
(1976)
J. Biol. Chem.
251,
3338-3345 11.
Samuel, C. E.,
and Rabinowitz, J. C.
(1974)
J. Biol. Chem.
249,
1198-1206 12.
Schweizer, H. P.,
and Hong, T. T.
(1995)
Gene (Amst.)
158,
15-22[CrossRef][Medline]
[Order article via Infotrieve]
13.
Schweizer, H. P.
(1993)
BioTechniques
15,
831-833[Medline]
[Order article via Infotrieve]
14.
West, S. E. H.,
Schweizer, H. P.,
Dall, C.,
Sample, A. K.,
and Runyen-Janecky, L. J.
(1994)
Gene (Amst.)
128,
81-86
15.
Newton, D. T.,
and Mangroo, D.
(1999)
Biochem. J.
339,
64-69[CrossRef]
16.
Newton, D. T., Lo, R. Y. C., and Mangroo, D. (1998)
Canadian Society for Microbiology Meeting, June
15-19, Guelph, Ontario, Canada, Abstract GMp 23
17.
Ebbole, D. J.,
and Zalkin, H.
(1987)
J. Biol. Chem.
262,
8274-8287 18.
Baumstark, B. R.,
Spremulli, L. L.,
RajBhandary, U. L.,
and Brown, G. M.
(1977)
J. Bacteriol.
129,
457-471 19.
Danchin, A.
(1973)
FEBS Lett.
34,
327-332[CrossRef][Medline]
[Order article via Infotrieve]
20.
Harvey, R. J.
(1973)
J. Bacteriol.
114,
309-322 21.
Arnold, H.
(1977)
Biochim. Biophys. Acta
476,
76-87[Medline]
[Order article via Infotrieve]
22.
Hamilton, C. M.,
Aldea, M.,
Washburn, B. K.,
Babitzke, P.,
and Kushner, S. R.
(1989)
J. Bacteriol.
171,
4617-4622 23.
Smith, A. E.,
and Mercker, K. A.
(1970)
Nature
226,
607-610[CrossRef][Medline]
[Order article via Infotrieve]
24.
Sprinzl, M.,
Steegborn, C.,
Hubel, F.,
and Steinberg, S.
(1996)
Nucleic Acids Res.
24,
68-72 25.
Laalami, S.,
Putzer, H.,
Plumbridge, J.,
and Grunberg-Manago, M.
(1991)
J. Mol. Biol.
220,
335-349[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Dybvig, C. Zuhua, P. Lao, D. S. Jordan, C. T. French, A.-H. T. Tu, and A. E. Loraine Genome of Mycoplasma arthritidis Infect. Immun., September 1, 2008; 76(9): 4000 - 4008. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Dean, S. Narayan, J. Richards, D. M. Daigle, S. Esterow, J. A. Leeds, H. Kamp, X. Puyang, B. Wiedmann, D. Mueller, et al. Reduced Susceptibility of Haemophilus influenzae to the Peptide Deformylase Inhibitor LBM415 Can Result from Target Protein Overexpression Due to Amplified Chromosomal def Gene Copy Number Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Nilsson, A. Zorzet, A. Kanth, S. Dahlstrom, O. G. Berg, and D. I. Andersson Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes PNAS, May 2, 2006; 103(18): 6976 - 6981. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E.F. D'Orazio, C. A. Shaw, and M. N. Starnbach H2-M3-restricted CD8+ T cells are not required for MHC class Ib-restricted immunity against Listeria monocytogenes J. Exp. Med., February 21, 2006; 203(2): 383 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Saxena and P. K. Chakraborti Identification of Regions Involved in Enzymatic Stability of Peptide Deformylase of Mycobacterium tuberculosis J. Bacteriol., December 1, 2005; 187(23): 8216 - 8220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. R. Vasconcelos, H. B. Ferreira, C. V. Bizarro, S. L. Bonatto, M. O. Carvalho, P. M. Pinto, D. F. Almeida, L. G. P. Almeida, R. Almeida, L. Alves-Filho, et al. Swine and Poultry Pathogens: the Complete Genome Sequences of Two Strains of Mycoplasma hyopneumoniae and a Strain of Mycoplasma synoviae J. Bacteriol., August 15, 2005; 187(16): 5568 - 5577. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Waites, N. B. Reddy, D. M. Crabb, and L. B. Duffy Comparative In Vitro Activities of Investigational Peptide Deformylase Inhibitor NVP LBM-415 and Other Agents against Human Mycoplasmas and Ureaplasmas Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2541 - 2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Charriere, T. H. P. Tan, and A. Schneider Mitochondrial Initiation Factor 2 of Trypanosoma brucei Binds Imported Formylated Elongator-type tRNAMet J. Biol. Chem., April 22, 2005; 280(16): 15659 - 15665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Steiner-Mosonyi, C. Creuzenet, R. A. B. Keates, B. R. Strub, and D. Mangroo The Pseudomonas aeruginosa Initiation Factor IF-2 Is Responsible for Formylation-independent Protein Initiation in P. aeruginosa J. Biol. Chem., December 10, 2004; 279(50): 52262 - 52269. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gil, F. J. Silva, J. Pereto, and A. Moya Determination of the Core of a Minimal Bacterial Gene Set Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 518 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ramesh, C. Kohrer, and U. L. RajBhandary Expression of Escherichia coli Methionyl-tRNA Formyltransferase in Saccharomyces cerevisiae Leads to Formylation of the Cytoplasmic Initiator tRNA and Possibly to Initiation of Protein Synthesis with Formylmethionine Mol. Cell. Biol., August 1, 2002; 22(15): 5434 - 5442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thanedar, T. K. Dineshkumar, and U. Varshney The Mere Lack of rT Modification in Initiator tRNA Does Not Facilitate Formylation-Independent Initiation in Escherichia coli J. Bacteriol., December 15, 2001; 183(24): 7397 - 7402. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Margolis, C. Hackbarth, S. Lopez, M. Maniar, W. Wang, Z. Yuan, R. White, and J. Trias Resistance of Streptococcus pneumoniae to Deformylase Inhibitors Is Due to Mutations in defB Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2432 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Apfel, S. Evers, C. Hubschwerlen, W. Pirson, M. G. P. Page, and W. Keck Peptide Deformylase as an Antibacterial Drug Target: Assays for Detection of Its Inhibition in Escherichia coli Cell Homogenates and Intact Cells Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1053 - 1057. [Abstract] [Full Text] |
||||
![]() |
J. M. Clements, R. P. Beckett, A. Brown, G. Catlin, M. Lobell, S. Palan, W. Thomas, M. Whittaker, S. Wood, S. Salama, et al. Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor Antimicrob. Agents Chemother., February 1, 2001; 45(2): 563 - 570. [Abstract] [Full Text] |
||||
![]() |
P. S. Margolis, C. J. Hackbarth, D. C. Young, W. Wang, D. Chen, Z. Yuan, R. White, and J. Trias Peptide Deformylase in Staphylococcus aureus: Resistance to Inhibition Is Mediated by Mutations in the Formyltransferase Gene Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1825 - 1831. [Abstract] [Full Text] |
||||
![]() |
Y. Li, W. B. Holmes, D. R. Appling, and U. L. RajBhandary Initiation of Protein Synthesis in Saccharomyces cerevisiae Mitochondria without Formylation of the Initiator tRNA J. Bacteriol., May 15, 2000; 182(10): 2886 - 2892. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |